Reoperation for XXXX .

@entity1 @entity295 @entity281 @entity881 @entity1011
A retrospective study of 50 @entity1 undergoing reoperation for @entity295 was performed to evaluate the ability of commonly available clinical and laboratory tests to predict the findings at reoperation and the outcome after operation. The influence of @entity881 on these parameters was also studied. No laboratory finding helped to predict operative findings. Computed tomographic scanning (80% accurate) was the most helpful radiographic procedure. A low total lymphocyte count and a high serum @entity1011 level both predicted a fatal outcome. No single organ failure or combination predicted a positive reexploration. Infection was found in 75 per cent of @entity1 with @entity881 and 79 per cent of @entity1 who did not have this syndrome. @entity1 having three-organ failure did have a significantly higher mortality. The mortality of a negative reexploration was 18.2 per cent, slightly lower than the 28.2 per cent mortality of @entity1 with a positive exploration. No @entity1 without organ failure died. The authors conclude that laboratory tests are not helpful in predicting the presence of @entity281 on reexploration, that the decision to reoperate is one based primarily on clinical judgment, and that if reoperation is performed before the development of organ failure, the risk associated with a negative exploration is worth taking.
